Home > Research Projects > RABBIT-SpA – Disease Register for Axial Spondyloarthritis and Psoriatic Arthritis
  • Joint grant

RABBIT-SpA – Disease Register for Axial Spondyloarthritis and Psoriatic Arthritis

The RABBIT-SpA disease register, established in May 2017, aims to investigate the long-term effectiveness and safety of therapies used in spondyloarthritis. Data from rheumatologists and patients on disease progression, treatment, therapy outcomes, and therapy safety are collected to gain a better understanding of the different treatment approaches. Aspects related to quality of life, mental health, and work ability are also the focus of our analyses. The web-based documentation system was developed in a way that allows additional modules to be integrated. Rheumatologists from both outpatient and inpatient care across Germany participate in the register. We are involved in national and international research collaborations.

Head of project

Sponsors and Advisory Board

Prof. Dr. med. Xenofon Baraliakos, Herne
Prof. Dr. med. Frank Behrens, Frankfurt
Prof. Dr. med. Uta Kiltz, Herne
Prof. Dr. med. Denis Poddubnyy, Toronto/Berlin
PD Dr. med. Dr. rer. biol. hum. David Simon, Berlin

Dieter Wiek, German Rheumatism League Federal Association e. V.

The RABBIT-SpA register is supported by long-term shared funding from various manufacturers of innovative drugs. The DRFZ has full academic freedom in conducting the register and publishing the results.

Abbvie, Amgen, Biocon Biologics, Biogen, Celltrion, Janssen-Cilag, Lilly, Novartis, Pfizer, UCB.

Figures from the RABBIT-SpA Register

As of April 2025

87

Participating Institutions

2143

Included axSpA Patients

2263

Included PsA Patients

AG Regierer

Registry Research in Rheumatology